Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes

Nephron

Volumn 76, Issue 3, 1997, Pages 323-330

  Tang, Zheng ^a   Shou, Ichiyu ^a   Wang, Li Ning ^a   Fukui, Mitsumine ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antihypertensive drugs; Glomerular antioxidant enzyme activities; Glycemic control; Spontaneously hypertensive rat

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; CAPTOPRIL; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; MANGANESE SUPEROXIDE DISMUTASE; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; ENZYME ACTIVITY; GLOMERULUS; HYPERGLYCEMIA; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD GLUCOSE; CAPTOPRIL; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG THERAPY, COMBINATION; GLUTATHIONE PEROXIDASE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYPERTENSION; KIDNEY GLOMERULUS; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RESERPINE; SUPEROXIDE DISMUTASE;

EID: 0030832493     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190199     Document Type: Article

References (22)

1. The National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group Report on hypertension on diabetes, Hypertension 1994;23:145-158.
2. Cooper ME, Mien TJ, Macmillan PA, Clarke BE, O’Brien RC, Jerttms G, Doyle AE: Effects of genetic hypertension on diabetic nephropathy in the rat: Functional and structural characteristics, J Hvpertens 1988:6:1009-1016.
3. Cooper ME, Allen TJ, Macmillan PA, Clarke BE, Jerums G, Doyle AE: Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat, Diabctologia 1989:32:326-328.
4. Stratta P, Canvcse C, Dogliani M, Mazzucco G, Monga G, Verccllonc A: The role of free radicals in the progression of renal disease, Kidney Int 1991; 17(suppl):33-37.
5. Shav SV: Role of reactive oxygen metabolites in experimental glomerular disease, Kidney Int 1989;35:1093-1106.
6. Tomino Y, Wang LN, Fukui M, Yaguchi Y, Koide H: Glomerular nonenzymatic glycosyla-tion and lipid peroxide arc increased in the early phase of streptozotocin-induccd diabetic rats prior to major histologic alterations, Nephron 1991;59:632-636.
7. Yaguchi Y, Tomino Y, Waianabe A, Koide H: Detection of malondialdehvde levels and superoxide dismutasc activities in renal tissue of non-obese diabetic mice, Nephron 1990:54: 368.
8. Brawn MK, Chiou WJ, Leach KL: Oxidant-induced activation of protein kinase C in UCIIMG cells, Free Radic Res 1995:22:23-37.
9. Tada H, Kuboi K, Ishii H, Tsukamoto M, Iso-gai S: Impaired degradation of hydrogen peroxide in isolated glomeruli of streptozotocin-induced diabetic rat (abstract), Diabetes 1994: 43(suppl 1):104A.
10. Fabiny DL, Ertingshausen G: Automated rcac-tion-rate method for determination of serum creatinine with the Centrifichcm, Clin Chem 1971:17:696-700.
11. Hyvarinen A, Nikkila EA: Specific determination of blood glucose with o-toluidinc, Clin ChimActa 1962;7:140-143.
12. Ohyanagi Y: Reevaluation of assay methods and establishment of kit for superoxide dismu-tase activity, Anal Biochem 1984; 142:290-296.
13. Flohe L, Gunzler WA: Assays of glutathione peroxidase, Methods Enzymol 1984; 105:114-121.
14. Aebi HE: Catalase; in Bergnteycr HU (ed): Methods of Enzymatic Analysis, ed 3. Wein-heim, Verlag Chemie, 1982. vol III, pp 273-282.
15. Shirato I, Sakai T, Fukui M, Tomino Y, Koide H: Widening of a capillary neck and alteration of extracellular matrix ultrastructure in diabetic rat glomerulus as revealed by computer morphometry and improved tissue processing, Virchows Arch A Pathol Anat Histopathol 1993: 423:121-129.
16. Morel DM, Chisolm GM: Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity, J Lipid Res I989;30: 1827-1834.
17. Malinski T, Kapturczak M, Dayharsh J, Bohr DF: Nitric oxide synthase activity in genetic hypertension, Biochem Biophys Res Commun 1993;194:654-658.
18. Giugliano DG, Ceriello A, Paolisso G: Diabetes mellitus, hypertension, and cardiovascular disease: Which role for oxidative stress? Metabolism 1995:44:363-368.
19. Nakamura T, Takahashi T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H: Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats, J Am Soc Nephrol 1995:5:1492-1497.
20. Captoten' (captopril) tablets: Physicians’Desk References: consult 1992 supplements for revision, p 225.
21. Parsing H-H, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy, BMJ 1988:297:1086-1091.
22. Cooper ME, Rumble CJ, Allen TJ, O’Brien RC, Jermus G, Doyle AE: Antihypcrtensive therapy in a model combining spontaneous hypertension with diabetes, Kidney Int 1992;41: 898-903.